[F-18]-fluorodeoxyglucose PET-CT of the normal prostate gland

Annals of Nuclear Medicine

Volumn 22, Issue 9, 2008, Pages 787-793

  Jadvar, Hossein ^a   Ye, Wei ^a   Groshen, Susan ^a   Conti, Peter S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

FDG; PET CT; Prostate

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; AGE; AGED; ARTICLE; CALCULATION; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION COEFFICIENT; GLUCOSE METABOLISM; HUMAN; IMAGE ANALYSIS; MALE; NORMAL HUMAN; ORGAN SIZE; POSITRON EMISSION TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSTATE; RADIOPHARMACEUTICALS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 57049150308     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-008-0177-5     Document Type: Article

References (33)

1. P.S. Conti D.L. Lilien K. Hawley J. Keppler S.T. Grafton J.R. Bading 1996 PET and [F-18]-FDG in oncology: a clinical update Nucl Med Biol 23 717 735
2. H. Jadvar A.J. Fischman 1999 Evaluation of rare tumors with [F-18]fluorodeoxyglucose positron emission tomography Clin Positron Imaging 2 153 158
3. L. Kostakoglu H. Agress Jr S.J. Goldsmith 2003 Clinical role of FDG PET in evaluation of cancer patients Radiographics 23 315 340
4. Frank IN, Graham S Jr, Nabors WL. Urologic and male genital cancers. In: Holleb AI, Fink DJ, Murphy GP, editors. Clinical oncology. Atlanta: American Cancer Society; 1991. p. 280-283.
5. J.E. Johansson O. Andren S.O. Andersson P.W. Dickman L. Holmberg A. Magnuson 2004 Natural history of early, localized prostate cancer JAMA 291 2713 2719
6. F. Algaba I. Trias Y. Arce 2007 Natural history of prostate carcinoma: the pathologist's perspective Recent Results Cancer Res 175 9 24
7. P.D. Shreve H.B. Grossman M.D. Gross R.L. Wahl 1996 Metastatic prostate cancer: initial findings of PET with FDG Radiology 199 751 756
8. N. Oyama H. Akino H. Kanamaru K. Okada 1998 Fluorodeoxyglucose positron emission tomography in diagnosis of untreated prostate cancer Nippon Rinsho 56 2052 2055
9. N. Oyama H. Akino Y. Suzuki H. Kanamaru N. Sadato Y. Yonekura 1999 The increased accumulation of [18F]fluorodeoxyglucose in untreated prostate cancer Jpn J Clin Oncol 29 623 629
10. H. Kanamaru N. Oyama J. Akino K. Okada 2000 Evaluation of prostate cancer using FDG-PET Hinyokika Kiyo 46 851 853
11. N. Oyama H. Akino Y. Suzuki H. Kanamaru H. Ishida K. Tanase 2001 FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablation Nucl Med Commun 22 963 969
12. C.H. Chang H.C. Wu J.J. Tsai Y.Y. Shen S.P. Chanqlai A. Kao 2003 Detecting metastatic pelvic lymph nodes by 18F-2-deoxyglucose positron emission tomography in patients with prostate-specific antigen relapse after treatment for localized prostate cancer Urol Int 70 311 315
13. H. Jadvar J.K. Pinski P.S. Conti 2003 FDG PET in suspected recurrent and metastatic prostate cancer Oncol Rep 10 1485 1488
14. H. Jadvar L. Xiankui A. Shahinian R. Park M. Tohme J. Pinski 2005 Glucose metabolism of human prostate cancer mouse xenografts Mol Imaging 4 91 97
15. J. Sung J.I. Espiritu G.M. Segall M.K. Terris 2003 Fluorodeoxyglucose positron emission tomography studies in the diagnosis and staging of clinically advanced prostate cancer BJU Int 92 24 27
16. H. Schoder K. Herrmann M. Gonen H. Hricak S. Eberhard P. Scardino 2005 2-[18F]fluoro-2-deoxyglucose positron emission tomography for detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy Clin Cancer Res 11 4761 4769
17. S.M. Larson M. Morris I. Gunther B. Beattie J.L. Humm T.A. Akhurst 2004 Tumor localization of 16beta-18F-fluoro-5aplpha-dihyrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer J Nucl Med 45 366 373
18. V. Ludwig O.W. Hopper W.H. Martin R. Kikkawa D. Delbeke 2003 [18F]fluorodeoxyglucose positron emission tomography surveillance of hepatic metastases from prostate cancer following radiofrequency ablation: a case report Am Surg 69 593 598
19. M.J. Morris T. Akhurst I. Osman R. Nunez H. Macapinlac K. Siedlecki 2002 Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer Urology 59 913 918
20. M.J. Morris T. Akhurst S.M. Larson M. Ditullio E. Chu K. Siedlecki 2005 Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy Clin Cancer Res 11 3210 3216
21. N. Oyama J. Kim L.A. Jones N.M. Mercer J.A. Engelbach T.L. Sharp 2002 MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model Nucl Med Biol 29 783 790
22. J. Bucerius H. Ahamadzadehfar N. Hortling A.Y. Joe H. Palmedo H.J. Biersack 2007 Incidental diagnosis of a PSA-negative cancer by (18)FDG PET/CT in a patient with hypopharyngeal cancer Prostate Cancer Prostatic Dis 10 307 310
23. D.B. Agus D.W. Golde G. Squouros A. Ballanqrud C. Cordon-Cardo H.I. Scher 1998 Positron emission tomography of a human prostate cancer xenograft: association of changes in deoxyglucose accumulation with other measures of outcome following androgen withdrawal Cancer Res 58 3009 3014
24. N. Oyama H. Akino Y. Suzuki H. Kanamaru Y. Miwa H. Tsuka 2002 Prognostic value of 2-deoxy-2-[F-18]fluoro-d-glucose positron emission tomography imaging for patients with prostate cancer Mol Imaging Biol 4 99 104
25. K.R. Zasadny R.L. Wahl 1993 Standardized uptake value of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-d-glucose: variations with body weight and a method for correction Radiology 189 847 850
26. N. Takahashi T. Inoue J. Lee T. Yamaguchi K. Shizukuishi 2007 The roles of PET and PET/CT in the diagnosis and management of prostate cancer Oncology 72 226 233
27. C.R. Pound A.W. Partin M.A. Eisenberger D.W. Chan J.D. Pearson P.C. Walsh 1999 Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1591 1597
28. E.C. Etchebehere H.A. Macapinlac M. Gonen K. Humm H.W. Yeung T. Akhurst 2002 Qualitative and quantitative comparison between images obtained with filtered back projection and iterative reconstruction in prostate cancer lesions of 18F-FDG PET Q J Nucl Med 46 122 130
29. A. Turlakow S.M. Larson F. Coakley T. Akhurst M. Gonen H.A. Macapinlac 2001 local detection of prostate cancer by positron emission tomography with 2-fluorodeoxyglucose: comparison of filtered back projection and iterative reconstruction with segmented attenuation correction Q J Nucl Med 45 235 244
30. C. Fan M. Hernandez-Pampaloni M. Houseni W. Chamroonrat S. Basu R. Kumar 2007 Age-related changes in the metabolic activity and distribution of the red marrow as demonstrated by 2-deoxy-2-[F-18]fluoro-d-glucose-positron emission tomography Mol Imaging Biol 9 300 307
31. Y. Wang R. Chiu J. Rosenberg S.S. Gambhir 2007 Standardized uptake value atlas: characterization of physiological 2-deoxy-2-[18F]fluoro-d-glucose uptake in normal tissues Mol Imaging Biol 9 83 90
32. D. Well H. Yang M. Houseni S. Iruvuri S. Alzeair M. Sansovini 2007 Age-related structural and metabolic changes in the pelvic reproductive end organs Semin Nucl Med 37 173 184
33. A. Pugachev S. Ruan S. Carlin S.M. Larson J. Campa C.C. Ling 2005 Dependence of FDG uptake on tumor microenvironment Int J Radiat Oncol Biol Phys 62 545 553